? OVERALL COMPONENT The Northwestern ADC is in its 20th year. This renewal application describes the progress of the past cycle and a plan of action for the next 5 years, during which we will pursue the following principal goals: A) Support innovative research at Northwestern University on the biology, early diagnosis, risk factors, and treatment of dementias by bringing together basic and clinical investigators. B) Participate in national collaborations that leverage the strengths of the NIA Centers by using the UDS, transmitting data to NACC, and participating in ADNI, ADCS, NCRAD, LOAD and ADGC. C) Serve a leadership role in FTLD neuropathology, primary progressive aphasia (PPA) and unusually successful brain aging in keeping with the unique strengths of the Northwestern ADC in this area of aging and dementia research. D) Train fellows and junior faculty and attract new investigators to dementia research through accredited clinical fellowships and training grants. E) Ensure that patients, families, and underserved populations are beneficiaries of relevant advances through education, outreach, and novel life enrichment programs. The cores of the ADC are configured to serve the specific goals listed above. The Administrative Core will be responsible for the clinical, scientific and fiscal leadership of the entire ADC, as well as the coordination with national consortia and the selection of projects for pilot funding. The Clinical Core will maintain a cohort of characterized subjects recruited to address ongoing research priorities. The Data Management and Statistics Core will ensure that the data are stored in ways that maximize collaboration and that biostatistic analysis plays a key role in the design and interpretation of research. The Neuropathology Core will characterize patients who come to autopsy according to up-to-date criteria, and distribute tissue, slides, DNA, and data for local and national collaborations. The Outreach and Recruitment Core will work with the Clinical Core to enhance subject recruitment into the ADC, and will develop innovative life enrichment programs to serve patients and their families. The Research Education Component will oversee diversity recruitment for researchers and junior faculty and will coordinate training requirements for the Responsible Conduct of Research. The Executive Committee, composed of all key personnel, will formulate Center priorities based on local and national mandates and will review requests for patients, controls, tissue, and data according to these priorities.

Public Health Relevance

- OVERALL Alzheimer's disease (AD) is one of the most urgent health care concerns facing the United States. The AD Centers funded by the NIA provide a national network of resources and researchers aiming to discover the causes and treatments of this disease and related dementias. The Northwestern ADC is part of this network and serves a leadership role in research on the causes and treatments of AD and related dementias and also on the factors that promote unusually successful brain aging.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Center Core Grants (P30)
Project #
5P30AG013854-23
Application #
9525218
Study Section
Special Emphasis Panel (ZAG1)
Program Officer
Silverberg, Nina B
Project Start
1997-07-15
Project End
2021-06-30
Budget Start
2018-08-01
Budget End
2019-06-30
Support Year
23
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Northwestern University at Chicago
Department
Neurology
Type
Schools of Medicine
DUNS #
005436803
City
Chicago
State
IL
Country
United States
Zip Code
60611
Barnes, Josephine; Bartlett, Jonathan W; Wolk, David A et al. (2018) Disease Course Varies According to Age and Symptom Length in Alzheimer's Disease. J Alzheimers Dis 64:631-642
Bergeron, David; Gorno-Tempini, Maria L; Rabinovici, Gil D et al. (2018) Prevalence of amyloid-? pathology in distinct variants of primary progressive aphasia. Ann Neurol 84:729-740
Kim, Garam; Bolbolan, Kabriya; Gefen, Tamar et al. (2018) Atrophy and microglial distribution in primary progressive aphasia with transactive response DNA-binding protein-43 kDa. Ann Neurol 83:1096-1104
Pottier, Cyril; Zhou, Xiaolai; Perkerson 3rd, Ralph B et al. (2018) Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study. Lancet Neurol 17:548-558
Gefen, Tamar; Papastefan, Steven T; Rezvanian, Aras et al. (2018) Von Economo neurons of the anterior cingulate across the lifespan and in Alzheimer's disease. Cortex 99:69-77
Kim, Garam; Vahedi, Shahrooz; Gefen, Tamar et al. (2018) Asymmetric TDP pathology in primary progressive aphasia with right hemisphere language dominance. Neurology 90:e396-e403
Burke, Shanna L; Maramaldi, Peter; Cadet, Tamara et al. (2018) Decreasing hazards of Alzheimer's disease with the use of antidepressants: mitigating the risk of depression and apolipoprotein E. Int J Geriatr Psychiatry 33:200-211
Weintraub, Sandra; Besser, Lilah; Dodge, Hiroko H et al. (2018) Version 3 of the Alzheimer Disease Centers' Neuropsychological Test Battery in the Uniform Data Set (UDS). Alzheimer Dis Assoc Disord 32:10-17
Qian, Winnie; Fischer, Corinne E; Schweizer, Tom A et al. (2018) Association Between Psychosis Phenotype and APOE Genotype on the Clinical Profiles of Alzheimer's Disease. Curr Alzheimer Res 15:187-194
Wilmoth, Kristin; LoBue, Christian; Clem, Matthew A et al. (2018) Consistency of traumatic brain injury reporting in older adults with and without cognitive impairment. Clin Neuropsychol 32:524-529

Showing the most recent 10 out of 443 publications